Feedback / Questions
dendrimer N-acetyl-cysteine (OP-101) - Ashvattha Therap
https://www.businesswire.com/news/home/20200831005184/en/Ashvattha-Therapeutics-Subsidiary-Orpheris-Enrolls-Patients-Phase
Aug 31, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next